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ElectrophysiologyMutations in the KCNQ2 gene, encoding for voltage-gated Kv7.2 K+ channel subunits, are responsible for early-
onset epileptic diseases with widely-diverging phenotypic presentation, ranging from Benign Familial Neonatal
Seizures (BFNS) to epileptic encephalopathy. In the present study, Kv7.2 BFNS-causing mutations (W344R,
L351F, L351V, Y362C, and R553Q) have been investigated for their ability to interfere with calmodulin (CaM)
binding and CaM-induced channel regulation. To this aim, semi-quantitative (Far-Western blotting) and quanti-
tative (Surface Plasmon Resonance and dansylated CaM ﬂuorescence) biochemical assays have been performed
to investigate the interaction of CaM with wild-type or mutant Kv7.2 C-terminal fragments encompassing the
CaM-binding domain; in parallel, mutation-induced changes in CaM-dependent Kv7.2 or Kv7.2/Kv7.3 current
regulation were investigated by patch-clamp recordings in Chinese Hamster Ovary (CHO) cells co-expressing
Kv7.2 or Kv7.2/Kv7.3 channels and CaM or CaM1234 (a CaM isoform unable to bind Ca2+). The results obtained
suggest that each BFNS-causing mutation prompts speciﬁc biochemical and/or functional consequences; these
range from slight alterations in CaM afﬁnity which did not translate into functional changes (L351V), to a signif-
icant reduction in the afﬁnity and functional modulation by CaM (L351F, Y362C or R553Q), to a complete func-
tional loss without signiﬁcant alteration in CaM afﬁnity (W344R). CaM overexpression increased Kv7.2 and
Kv7.2/Kv7.3 current levels, and partially (R553Q) or fully (L351F) restored normal channel function, providing
a rationale pathogeneticmechanism formutation-induced channel dysfunction in BFNS, and highlighting the po-
tentiation of CaM-dependent Kv7.2 modulation as a potential therapeutic approach for Kv7.2-related epilepsies.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Mutations in the KCNQ2 gene, encoding for Kv7.2 voltage-gated K+
channel subunits, are responsible for a wide spectrum of early-onset
human epileptic diseases. These range from Benign Familial Neonatal
Seizures (BFNS; OMIM: 121200), an autosomal-dominant epilepsy of
newborns characterized by recurrent seizures that begin in the very
ﬁrst days of life and remit after a few weeks or months, with mostly, Dulbecco's Modiﬁed Eagle's
O, Chinese Hamster Ovary; RT,
sopropyl-β-D-thiogalactoside;
face Plasmon Resonance; BFNS,
d Health Sciences, University of
la).
uld be considered ﬁrst authors.normal interictal electroencephalogram (EEG), neuroimaging, and psy-
chomotor development [1,2], to epileptic encephalopathies in which
pharmacoresistant seizures, distinct EEG and neuroradiological features
are associated to various degrees of developmental delay (Epileptic en-
cephalopathy, early infantile, 7; OMIM: 613720; [3,4]).
Kv7.2 subunits, in some cases together with highly homologous
Kv7.3 subunits encoded by the KCNQ3 gene, underlie the M-current
(IKM) [5], a K+-selective current which is suppressed by Gq-linked neu-
rotransmitter receptors activation and plays a critical role in neuronal
excitability control [6,7]. Kv7 channels are tetramers of subunits
each showing six transmembrane segments (S1–S6), and cytoplasmic
N- and C-termini of variable length. The pore domain is encompassed
by the S5–S6 segments and the intervening linker, whereas the trans-
membrane segments between S1 and S4 form the voltage-sensing do-
main (VSD), with S4 charged and uncharged residues contributing to
voltage-dependent gating [8–10]. The long C-terminal domain plays a
crucial role in Kv7.2 channel function and regulation: in fact, it contains
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(sid) [11,12] and for a complex network of mutually interacting mole-
cules, such as phosphatidylinositol 4,5-bisphosphate (PIP2; [13]), cal-
modulin (CaM; [14,15]), syntaxin-1A [16], A-kinase-anchoring
proteins (AKAPs), which allows Kv7 channel regulation by protein ki-
nase C (PKC; [17]), and ankyrin-G (Ank-G; [18]). A complex interplay
among these regulatory molecules is suggested by the observation
that they often bind to overlapping regions within the Kv7.2 C-
terminus; in fact, the CaM binding site, which involves two putatively
α-helical regions (A and B helices; see Fig. 1A), partially overlaps with
that for PIP2 [19], AKAPs [20], syntaxin-1A [21] and contains putative
phosphorylation sites for PKC [14,17]. The pathophysiological role of
the C-terminal region in Kv7.2-related epilepsies is suggested by this re-
gion being a hot-spot for disease-causing mutations [3]; among these,
we have recently described Kv7.2 mutations falling within the A
(W344R, L351F, L351V) or the B (R553Q) helices, or in the A–B inter-
helical region (Y362C) in a large cohort of BFNS-affected families [22];
therefore, in the present work, the biochemical and functional conse-
quences prompted by these mutations on CaM binding and CaM-
dependent functional regulation were investigated. To this aim, bio-
chemical studies were performed using both Far-Western blotting,
which provides semi-quantitative information, and quantitative Surface
Plasmon Resonance (SPR) and dansylated CaM ﬂuorescence assays to
investigate the interaction of CaM with a Kv7.2 C-terminal fragment
encompassing the A and B helices. In parallel, possible mutation-
induced changes in CaM-dependent Kv7.2 and Kv7.2/Kv7.3 currentFig. 1. Interaction between Kv7.2CT and CaM studied by Far-Western blotting.
A) Topological representation of a Kv7.2 subunit. The red box indicates the fragment of
the C-terminal domain (from G310 to the L576 residues) cloned in pGEX vectors; the
“hA” and “hB”marked boxes indicate the A and Bα helical regions involved in CaM bind-
ing to Kv7.2 channels [14]. B) Representative image of Far-Western blot experiments
using bacterial lysates expressing wt or mutant GST-Kv7.2CT (prey) and GST-CaM (bait)
proteins. The interaction between GST–Kv7.2CT and CaM was tested both in the presence
(upper panel) and in the absence (middle panel) of Ca2+. In the lower panel, a represen-
tative image of an anti-GSTwestern-blot performedusing the samequantities of total bac-
terial lysates loaded in the upper panels, to check for equal loading of IPTG-induced GST–
Kv7.2CT fragments is reported.regulation were investigated by patch-clamp recordings in Chinese
Hamster Ovary (CHO) cells co-expressing Kv7.2 and/or Kv7.3 subunits
and CaM; furthermore, to investigate whether the observed functional
changes were dependent on the Ca2+-binding ability of CaM, electro-
physiological experiments were also carried out using a modiﬁed CaM
unable to bind Ca2+ (CaM1234) [23,24].
2. Materials and methods
2.1. Plasmid preparation
Plasmids for bacterial (pGEX-KG) or mammalian (pcDNA3.1) CaM
expression were kindly provided by Prof. M. S. Shapiro (University of
Texas at San Antonio, Texas, USA); plasmids for bacterial expression of
Kv7.2 C-terminal fragments encompassing the CaM binding site (GST-
Kv7.2CT; from G310 to L576, numbering according to the longest Kv7.2
isoform a, GenBank accession no. NM_172107.2) were engineered as
previously described [14]. The full-length Kv7.2 plasmid (encoding for
variant c, GenBank accession no. NM_004518.4) was kindly given by
Dr. Thomas J. Jentsch (Department of Physiology and Pathology of Ion
Transport, Leibniz-Institut für Molekulare Pharmakologie, Berlin,
Germany). BFNS-associated mutations (W344R, L351F, L351V, Y362C,
R553Q; [22]) were introduced in these plasmids by using Quick-
change mutagenesis, as previously described [25]. The successful intro-
duction of mutations was checked by direct sequencing of the entire
coding region.
2.2. Recombinant calmodulin expression and puriﬁcation
The expression of CaM and wild-type (wt) or mutant Kv7.2 C-
terminal fragments was obtained adapting previously described proto-
cols [26]. Brieﬂy, DH5α bacterial cells were transformed with pGEX
plasmids encoding for the proteins of interest fused to the glutathione
S-transferase (GST) coding sequence. Individual fresh colonies corre-
sponding to each positive clonewere inoculated in 10ml of LB and incu-
bated for 12-16 h at 37 °C. These cultures were subsequently used to
inoculate 1 l of LB medium and incubated at 37 °C until the OD550 nm
reached 0.5-0.6, when the cultures were added with 0.5 mM
isopropyl-β-D-thiogalactoside (IPTG) and left at 37 °C for 4 h to induce
the recombinant protein expression. Successful expression of each pro-
tein was checked by comparing total protein lysates from non-induced
or IPTG-induced bacterial lysates on 10% polyacrylamide gels. GST-CaM
puriﬁcation under native conditionswas then obtained by bacterial cul-
ture centrifugation at 12,000 g for 10′ at 4 °C, followed by pellet re-
suspension in GST buffer (containing 20 mM Tris–HCl, 100 mM NaCl,
1 mM EDTA, 0.5% Triton X-100, 1× protease inhibitors and lysozyme,
pH 8; [14]) and sonication in ice for 6 cycles, each lasting 10 s with a
10 s interval in between. For GST-CaM puriﬁcation, a chromatographic
column was loaded with Glutathione Sepharose 4B (GE Healthcare,
Piscataway, New Jersey, USA), washed with distilled H2O to remove
the excess of ethanol and equilibrated with GST buffer. Finally, the col-
umn was loaded with 0.22 μm-ﬁltered soluble fraction of the bacterial
suspension and left on a rotating wheel platform for 16 h at 4 °C: after
a GST washing, proteins bound were eluted by adding 10 mM reduced
glutathione dissolved in 50 mM Tris pH 8, and 5 fractions of 1 ml were
collected. Aliquots of each fraction were run on 10% polyacrylamide
gels in parallel with non-induced/IPTG-induced bacterial cultures to
check for successful CaMpuriﬁcation in the soluble fraction and to iden-
tify the highest concentrated fraction to be used in the following exper-
iments (Suppl. Fig. 1A).
2.3. Recombinant Kv7.2 constructs production and puriﬁcation
The previously described protocol for CaM only allowed recovering
of GST-Kv7.2CT fragments in the insoluble fraction (Suppl. Fig. 1B), irre-
spective of the presence of different or higher concentrations of
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(data not shown). As protein extraction from this fraction is very inefﬁ-
cient, often requiring the addition of denaturing detergents, recombi-
nant proteins from total lysates were used as previously described
[27]. To quantify induced proteins in total lysates, aliquots of IPTG-
induced total bacterial lysates expressing wt GST–Kv7.2CT fusion pro-
teins were run on 10% polyacrylamide gels, in parallel with an aliquot
of non-induced total lysate (Suppl. Fig. 1C); then, the strip of the gel
containing the non-induced and the ﬁrst aliquot of the IPTG-induced ly-
sate was Blue-stained (staining solution contained 45% MetOH, 45%
acetic acid, 0.01% Blue Coomassie) and used as reference to identify
the uncolored part of the gel containing the protein of interest. This
was excised from the gel and incubated for 16 h at 37 °C in an elution
buffer, containing (in mM): 50 Tris–HCl, 150 NaCl, 0.1 EDTA; pH 7.5.
The suspension was then centrifuged at 8000 rpm for 10′ at RT and
the protein concentration of the supernatant was determined by using
a bovine serum albumin calibration curve. Therefore, known quantities
of the protein lysates were run on 10% polyacrylamide gels to check the
successful GST-Kv7.2CT protein puriﬁcation and to ﬁnd the linearity
range for quantiﬁcation of wt and mutant GST-Kv7.2CT recombinant
proteins in total bacterial lysates (Suppl. Fig. 1D).
2.4. Western and Far-Western blotting experiments on bacterial lysates
Western- and Far-Western blotting experiments were performed as
previously described [28]. Brieﬂy, total lysates containing 15 μg of
recombinant GST–Kv7.2CT proteins (prey) were separated on 10% poly-
acrylamide gels and transferred for 1 h at 100 V at 4 °C on
polyvinylidene diﬂuoride (PVDF, Biorad, Milan, Italy) membranes. In
western-blotting experiments,membranes were incubated in 5% casein
dissolved in PBS-2% Tween (PBS-T) for 1 h at RT, to reduce unspeciﬁc
binding, before incubation with rabbit polyclonal anti-GST antibodies
(1:10.000; GE Healthcare) for 16 h at 4 °C and with anti-rabbit HRP-
conjugated secondary antibodies (1:5000; GE Healthcare) for 1 h at
RT. Reactive bands were detected by chemiluminescence (ECL Western
blotting Susbtrate; Promega Corporation). Images were captured,
stored, and analyzed with the ImageLab, version 4.1 analysis software
(Bio-Rad Laboratories, Milan, Italy).
In Far-Western blotting experiments, membraneswere incubated in
renaturating buffer (RenB: 100 mM NaCl, 20 mM Tris–HCl pH 7.6,
0.5mMEDTA, 10% glycerol, 0.1% Tween, 2% casein, 1mMdithiothreitol)
and reacted with gradually decreasing concentrations of guanidine hy-
drochloride (Applichem, Darmstadt, Germany). Then, membranes
were incubated in 5% casein dissolved in PBS-T 1 h at RT before incuba-
tion for 16 h at 4 °C with 5 μg of puriﬁed CaM (bait) dissolved in RenB
buffer. Unbound proteins were removed by washing with PBS-T for
30 min; membranes were then incubated with mouse monoclonal
anti-CaM antibodies (1:500; Millipore, Billerica, MA, USA) for 16 h at
4 °C and anti-mouse HRP-conjugated secondary antibodies (1:5000;
GE Healthcare). In Ca2+-free experiments, casein was omitted and
10 mM EDTA was added to all solutions. Acquisition and data analysis
was performed as above described.
2.5. Surface Plasmon Resonance (SPR) assays
Surface Plasmon Resonance (SPR) assays were performed as previ-
ously described [29]. Brieﬂy, experiments were performed at 25 °C
using a Biacore T100 instrument (GE Healthcare) and CM5 chips, pro-
vided of carboxymethyl dextran surface activated using a mixture of
0.4 M 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC) and
0.1 M N-hydroxysuccinimide (NHS) at a ﬂow rate of 10 μl/min for
7 min using a running buffer (RB), containing (in mM): 10 HEPES
pH 7.5, 150 NaCl, 4 CaCl2, 0.005% P-20 surfactant (GE Healthcare).
Ca2+ concentrations were chosen in analogy to previously reported
studies [30,31]. Optimal pH for CaM (ligand) immobilization was ob-
tained when 50 ng/μl GST-CaM was diluted in 10 mM NaAcetatepH 3.5 (the isoelectric point of the GST-CaM is 4.56 when measured
with the DNASTAR/LaserGene/EditSeq software, version 7.1.0). After
binding signal reached 4000 response units (RU), 1 M ethanolamine-
HCl pH 8.5 was injected at a ﬂow rate of 10 μl/min for 7 min of contact
time to deactivate remaining active ester groups. A single ﬂow cell on
the chip was activated and deactivated without ligand immobilization
and used as reference channel to subtract unspeciﬁc binding to the chip.
After GST-CaM immobilization, each bacterial lysate containing re-
combinant Kv7 fragments (analyte) diluted in RB was injected for
250 s (association time) from the lowest (0 nM; in double) to the
highest (5000 nM) concentration, followed by 300 s of dissociation
time. After each injection, the chip surface was regenerated by a single
20 s injection with 20 μl/min 10 mM EGTA, followed by four injections
each lasting 10 s with 30 μl/min of 20mMNaOH. Sensorgrams obtained
after RB injection (blank) in parallel experiments were subtracted from
binding signals to remove unspeciﬁc binding to CaM. Binding data were
analyzed using the BiaEvaluation Software 2.1 (GE Healthcare) and the
best ﬁt to the experimental data was obtained by using the conforma-
tional change model, described by the following equation:
dAB=dt ¼ ka1  A  B−kd1  ABð Þ– ka2  AB–kd2  AB′ð Þ
where AB andAB′ indicate the concentrations of the complex conforma-
tional states. From this equation, the dissociation constants (KD) were
measured as follows:
KD ¼ Kd1=Ka1ð Þ  Kd2= Kd2 þ Ka2ð Þ½ :
Non determined KD values were obtained when binding signals
were not correctly ﬁtted to this equation.
2.6. Fluorometric measurements using dansylated-calmodulin
Recombinant proteins encoding wt or mutant (W344R, L351F,
L351V, Y362C, R525Q or A343D) Kv7.2 CaM binding domain fused to
GST (GST-Kv7.2CT), were expressed in the BL21-DE3 strain of
Escherichia coli and obtained principally as inclusion bodies. These pro-
teins were refolded and puriﬁed following the procedures reported in
the literature [32]. Recombinant CaM was also produced in BL21-DE3
cells and puriﬁed as previously described [32]. Fluorescent dansylated
CaM (D-CaM, 5-(dimethylamino)naphtalene-1-sulfonyl-calmodulin)
was prepared using recombinant CaM and dansyl chloride, as described
[33]. Dispersion of the samples was evaluated by dynamic light scatter-
ing (DLS) using a Zetasizer Nano instrument (Malvern Instruments Ltd.,
Malvern, UK) in order to exclude the presence of aggregates.
Prior to the experiments, D-CaM and GST–Kv7.2CT constructs were
dialyzed for 48 h against 2 L of ﬂuorescence buffer containing (in mM)
25 Tris–HCl (pH 7.4), 120 KCl, 5 NaCl, 2 MgCl2, 10 EGTA; the buffer
was changed every 12 h. Steady-state ﬂuorescence measurements
were performed at RT with an Aminco Bowman series 2 (SLM Aminco)
ﬂuorescence spectrophotometer in a ﬁnal volume of 100 μl (using
quartz cuvette). The excitation wavelength was 340 nm and emissions
were recorded from 400 to 660 nm. Slit widths were set at 4 nm for
both excitation and emission.
Titration experiments were performed reacting increasing concen-
trations of GST-Kv7.2CT fusion proteins in ﬂuorescence buffer with
12.5 nM D-CaM. Experiments were also performed in the presence of
an excess of free Ca2+ (3.9 or 100 μM), adding 9.63 or 9.985 mM Ca2+
to the ﬂuorescence buffer. The data obtained at lower (3.9 μM, present-
ed in this report) and higher (100 μM) free Ca2+ concentrations were
indistinguishable. Free Ca2+ concentrations were determined using
Fura-2 (Invitrogen), following the manufacturer's instructions.
Fluorescence enhancementwas plotted against GST-Kv7.2CT protein
concentration and concentration–response curves were obtained by
ﬁttingaHill equation to thedata (ﬂuorescence increase=A×[Ligand]h /
EC50+ [Ligand]h, where A is themaximal ﬂuorescence increase and h is
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concentration that gives half-maximal change in ﬂuorescence emission
intensity) and Hill coefﬁcient. Data are shown as average of at least four
independent experiments.
2.7. Cell culture and transfections
CHO cells were grown in 100 mm plastic Petri dishes in Dulbecco's
Modiﬁed Eagle Medium (DMEM) containing 10% fetal bovine serum
(FBS), penicillin (100 IU/ml), and streptomycin (100 IU/ml) in a humid-
iﬁed atmosphere at 37 °C with 5% CO2. For electrophysiological experi-
ments, the cells were seeded on glass coverslips (Carolina Biological
Supply Company, Burlington, NC, USA) and transfected the next day
using Lipofectamine 2000 (LifeTechnologies, Milan, Italy). Plasmids
encoding for Kv7.2, Kv7.3 and CaM were transfected using different
cDNA ratios (ranging from 1:1 to 1:10); total cDNA in the transfection
mixture was kept constant at 4 μg (for electrophysiological experi-
ments) or at 6 μg (for biotinylation experiments).
2.8. Cell surface biotinylation and Western blotting
Plasma membrane expression of wt and mutant Kv7.2 subunits in
CHO cells co-expressing CaMor CaM1234 (transfection ratio 1:5)was in-
vestigated by surface biotinylation of membrane proteins in transfected
cells 24 h after transfection using Sulfo-NHS-LC-Biotin (Pierce), a cell-
membrane impermeable reagent, as previously described [22]. Follow-
ing cell transfection, biotinylation, and lysis (in a buffer containing 2%
Triton, 20 mM Tris–HCl pH 7.5, 120 mM NaCl, 50 mM KCl, 10 mM
EDTA, 50 mM NaF, 2 mM DTT), cell lysates were reacted with
ImmunoPure immobilized streptavidin beads (Pierce). Channel sub-
units in streptavidin precipitates and remaining total lysates were ana-
lyzed by Western blotting on 8–12% SDS-PAGE gels using mouse
monoclonal anti-Kv7.2 (clone N26A/23, dilution 1:1000; UC Davis/NIH
NeuroMab Facility, Davis, CA, USA) or mouse monoclonal anti-CaM
(05–173; 1:1000; Millipore, Billerica, MA, USA) antibodies, followed
by HRP-conjugated anti-mouse secondary antibodies (clone NA931V;
dilution 1:5000; GE Healthcare). Reactive bands were detected by
chemiluminescence (ClarityTMWestern ECL Substrate; Biorad). To con-
ﬁrm that the biotinylation reagent did not leak into the cell and label in-
tracellular proteins and to check for equal protein loading, the same
blots were also probed with anti-α-tubulin antibodies (dilution
1:5000; Sigma). Acquisition and data analysis were performed by
using ImageLab software (version 4.1; Bio-Rad).
2.9. Whole-cell electrophysiology
Macroscopic currents from transiently-transfected CHO cells were
recorded at RT 24h after transfections, with anAxopatch 200Aampliﬁer
(Molecular Devices, Union City, CA, USA) using the whole-cell conﬁgu-
ration of the patch-clamp technique and glass micropipettes of 3–5MΩ
resistance. The extracellular solution contained (mM): 138 NaCl,
5.4 KCl, 2 CaCl2, 1 MgCl2, 10 glucose, and 10 HEPES, pH 7.4 with
NaOH. The pipette (intracellular) solution contained (mM): 140 KCl, 2
MgCl2, 10 EGTA, 10 HEPES, 5 Mg-ATP, pH 7.3–7.4 with KOH. The
pCLAMP software (version 10.2; Molecular Devices) was used for data
acquisition and analysis.
Linear cell capacitance (C) was determined by integrating the area
under the whole-cell capacity transient, evoked by short (5–10 ms)
pulses from−80 to−75mVwith the whole-cell capacitance compen-
sation circuit of the Axopatch 200A turned off. All illustrated and ana-
lyzed currents were corrected ofﬂine for linear capacitance and
leakage currents using standard subtraction routines of the Clampﬁt
module of pClamp10. Current densities (expressed in pA/pF) were cal-
culated as peak K+ currents at 0 mV divided by C. Data were acquired
at 0.5–2 kHz and ﬁltered at 1–5 kHz with the 4-pole low-pass Besselﬁlter of the ampliﬁer. No corrections were made for liquid junction
potentials.
2.10. Statistics
Data are expressed as the mean ± SEM. Statistically-signiﬁcant dif-
ferences between the data (p b 0.05) were evaluated with the Student's
t-test or by one-way analysis of variance (ANOVA), followed by the
Newman–Keul test for comparison among multiple groups.
3. Results
3.1. Interaction between Kv7.2CT and CaM studied by Far-Western blotting
Epilepsy-causing mutations in Kv7.2 often affect the cytoplasmic C-
terminal region, an attachment site for several regulatory molecules
[34,35]. To investigate whether epilepsy-causing mutations in this re-
gion of Kv7.2 channels interfere with the binding of the ubiquitous
Ca2+-sensing protein CaM, Far-Western blotting experimentswere per-
formed. To this aim, wt or mutant GST–Kv7.2 C-terminal fragments
(Kv7.2CT; Fig. 1A) carrying the following mutations: W344R, L351F,
L351V, Y362C, or R553Q (naturally-occurring and disease-causing)
[22], or the A343D (which is known to abolish CaM binding and was
therefore used as negative control) [32,36] were used. IPTG-induced
bacterial cell lysates containing 15 μg of each of these constructs were
separated on polyacrylamide gels and, after protein renaturation,mem-
branes were incubated with 5 μg of puriﬁed CaM, both in the presence
and absence of Ca2+; anti-CaM antibodies were then used in Western-
blots to reveal possible mutation-induced changes in Kv7.2CT/CaM in-
teraction. As shown in Fig. 1B (upper panel), in the presence of Ca2+, a
speciﬁc 50 kDa band corresponding to the expected molecular mass of
the GST–Kv7.2CT fusion protein was detected in all lanes except in that
corresponding to A343D [32,36]. However, when compared to
wtKv7.2CT, the intensity of the W344R band was stronger (n = 4;
p b 0.05 versus wt) or lower in the case of L351F, Y362C or R553Q
(n = 3–4; p b 0.05 versuswt); by contrast, no changes in the intensity
of L351V (n= 3; p N 0.05 versuswt) was detected. Upon Ca2+ removal
(Fig. 1B, middle panel), the signals for L351F, L351V, Y362C or R553Q
were signiﬁcantly reduced compared to wtKv7.2CT (n= 3; p b 0.05 ver-
sus wt), whereas the W344R band was of similar intensity (n = 3;
p N 0.05 versus wt). In this experimental condition, the band corre-
sponding to A343D was also visible, although its intensity was much
lower than that of wtKv7.2CT (n = 3; p b 0.05 versuswt). Noteworthy,
the possibility that the observed changes in band intensities could be
accounted for by differences in the amount of loaded proteins is ruled
out by the results of Western blot experiments using anti-GST antibod-
ies which failed to reveal any change in band intensity between wt and
mutant Kv7.2CT (Fig. 1B, lower panel). Although Far-Western blotting
experiments only provide semi-quantitative data, these results suggest
that the Kv7.2 mutations herein investigated signiﬁcantly and differen-
tially alter CaM interaction, both in the presence and in the absence of
Ca2+.
3.2. Interaction between Kv7.2CT and CaM investigated by Surface Plasmon
Resonance (SPR)
To examine inmore detail the impact of themutations of interest on
the Kv7.2CT/CaM interaction, Surface Plasmon Resonance (SPR) experi-
ments, similar to those recently performed to investigate the interaction
of Kv7.1 C-terminal domain with the accessory subunit KCNE1 [37],
were performed. To this aim, increasing concentrations (0–1000 nM)
of Kv7.2CT from IPTG-induced bacterial lysates (quantiﬁed as described
in Suppl. Fig. 1C–D)were perfused onto CM5 chipswhere CaMhad been
previously immobilized (see Methods section for details); data were
only obtained in the presence of Ca2+, as CaM immobilization on the
SPR chip was not achieved when Ca2+-free solutions were used (data
Fig. 2. Interaction between Kv7.2CT and CaM investigated by Surface Plasmon Resonance (SPR) assays. A–B) Representative curves showing the increase (association phase) or the de-
crease (dissociation phase) in the response units when native CaM, immobilized on the chip, reacted with total bacterial lysates expressing GST–Kv7.2CT (A) or only GST (B) proteins.
Each color corresponds to binding sensorgrams obtained using different induced protein concentrations, as indicated. C) Quantiﬁcation of dissociation constants (KD) measured as de-
scribed inMethods section. Asterisks indicate values signiﬁcantly different (p b 0.05) versus wtKv7.2CT. Each bar is the mean ± SEM from 4 independent experiments.
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induced lysates from bacteria transformed with GST–Kv7.2CT or with
the empty vector (GST only) are shown in Figs. 2A and B, respectively.
Fitting Kv7.2CT sensorgrams to a conformational change binding
model resulted in a KD value of 31.5±10.2 nM for CaM (n=8); by con-
trast, no binding could be detected when bacterial lysates containing
0–1250 nM GST were perfused on the same chip. Instead, a signiﬁcant
decrease in binding afﬁnity was measured when fragments carrying
the A343D mutation were perfused (KD = 169.8 ± 38.3 nM; n = 5;
p b 0.05 versus wt). Similar results were obtained with L351F, Y362C,
or R553Q mutant constructs (KD values were 157.8 ± 21.5 nM,
173.3 ± 39.6 nM, and 203.2 ± 83.9 nM, respectively; n = 4–6;
p b 0.05 versus wt; p N 0.05 versus A343D–Kv7.2CT). By contrast,
W344R or L351V mutant constructs displayed KD values (22.2 ±
2.0 nM and 44.0 ± 9.5 nM, respectively; n= 4; p N 0.05 versuswt) sim-
ilar to those of wtKv7.2CT; noteworthy, consistent with the Far-Western
blotting results (see Fig. 1B, upper panel), W344R/CaM binding afﬁnity
showed a tendency to be slightly higher (lower KD value) than that of
wtKv7.2CT, although the data failed to reach statistical signiﬁcance.
3.3. Interaction between Kv7.2CT and CaM studied by dansyl-CaM
ﬂuorescence
Technical limitations precluded the assessment of the impact of the
mutations in the absence of Ca2+ by SPR. To ﬁll this gap, we turned to
the dansyl-CaM (D-CaM) ﬂuorescence assay; D-CaM is a CaM ﬂuores-
cent derivate that reports the binding to target peptides, Ca2+ or both,
based on the ﬂuorescence enhancement occurring when the environ-
ment of the dansyl group becomeshydrophobic [38];we have previous-
ly applied this technique to the study of CaM/Kv7.2CT interaction [31].
To this aim,D-CaM (12.5 nM)was incubatedwith increasing concentra-
tions (6.25–800 nM) of GST or GST–Kv7.2CT (wt or mutant), both in the
presence and in the absence of a physiologically relevant concentration
(3.9 μM) of free Ca2+, and the changes inﬂuorescence emission induced
by their interaction were measured (Fig. 3; Table 1). GST alone had no
effect on the ﬂuorescence spectrum of D-CaM both in the presence
and in the absence of Ca2+ (data not shown); similarly, we were unableto detect any signiﬁcant interaction between D-CaM and the A343D,
both in the presence and in the absence of Ca2+ (black plots in
Figs. 3A and B, respectively) [32]. wtKv7.2CT (red plots in Fig. 3) caused
a saturable, concentration-dependent ﬂuorescence enhancement, indi-
cating a direct interaction of this protein with CaM. The introduction
ofmutations in helix A (W344R, L351F, L351V), in the interhelical linker
(Y362C), or in the helix B (R553Q) of Kv7.2CT differently affected CaM
interaction. In fact, W344R (yellow plots) and wtKv7.2CT induced an
identical maximal increase of D-CaM ﬂuorescence emission, both in
the presence (Fig. 3A) and in the absence of Ca2+ (Fig. 3B); moreover,
when compared towt, theW344Rmutation slightly but signiﬁcantly in-
creased the apparent afﬁnity for CaM, both in the presence and in the
absence of Ca2+ (Fig. 3; Table 1). By contrast, the L351V mutation
(green plots), slightly, but signiﬁcantly reduced CaM afﬁnity, although
it failed to affect maximal ﬂuorescence intensity (Table 1). All the
other tested mutations induced a signiﬁcant decrease in the maximal
D-CaM ﬂuorescence emission and in CaM afﬁnity, both in the presence
and in the absence of Ca2+ (Fig. 3; Table 1). Reassuringly, the nanomolar
apparent afﬁnities for CaM obtained for wt and mutant Kv7.2CT con-
structs in D-CaM ﬂuorescence measurements were very similar to
those described from SPR experiments (Fig. 2C).
3.4. Mutations in the C-terminus interfere with the functional regulation of
Kv7.2 channels by CaM
In order to investigate the consequences of the observed changes in
CaM afﬁnity induced by the different C-terminus mutations on Kv7.2
channel function, we developed a functional assay of CaM–dependent
Kv7.2 current regulation. Expression of Kv7.2 subunits in CHO cells
gave rise to typical outward K+ currents with a threshold potential for
activation of about −40 mV [22] (Fig. 4A), and a current density at
0 mV of 28.1 ± 3.4 pA/pF (n= 12). CaM co-expression with Kv7.2 sub-
units induced a dose-dependent increase of Kv7.2 current density
(Fig. 4D). In fact, while a Kv7.2:CaM cDNA transfection ratio of 1:1 or
1:3 failed tomodify themaximal current density (n= 8; p N 0.05 versus
cells expressing Kv7.2), a signiﬁcant increase was instead measured
when a transfection ratio of 1:5 was used (n = 30; p b 0.05 versus
Fig. 3. Interaction between Kv7.2CT and CaM studied byD-CaM ﬂuorescence. A–B) Concentration–ﬂuorescence curves obtained by reacting 12.5 nMD-CaMwith increasing concentrations
of the indicated GST-fusion proteins in the presence (A) or in the absence (B;+10mMEGTA) of Ca2+, as indicated. Data are themeans± SEM of at least 4 independent experiments and
are expressed as % of the ﬂuorescence increase measured when D-CaM was reacted with wtGST–Kv7.2CT. C) Apparent binding afﬁnities (EC50) derived from the data shown in A (white
columns) or in B (black columns). Asterisks indicate values signiﬁcantly different (p b 0.05) versus wtGST–Kv7.2CT.
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failed to further enhance Kv7.2 currents. Co-expression of Kv7.2 with
a mutant CaM unable to bind Ca2+ (CaM1234; transfection ratio
Kv7.2:CaM1234 = 1:5 or 1:10) [23], exerted even larger effects on
Kv7.2 current density (n = 30; p b 0.05 versus cells expressing Kv7.2
or Kv7.2 + CaM; Fig. 4A). These results suggested that CaM-induced
Kv7.2 current increase was largely independent on its Ca2+-binding
ability. In addition to increasing maximal current size, CaM1234 over-
expression also caused a strong leftward shift in the voltage-
dependence of activation of Kv7.2-mediated currents; by contrast,
CaMonly caused a small (less than 2mV) rightward shift in Kv7.2 chan-
nels gating (Table 2).
To investigate the molecular mechanism underlying CaM- or
CaM1234-dependent Kv7.2 current potentiation, Western blot experi-
ments were performed in cells in which Kv7.2 cDNA was co-
transfected with CaM or CaM1234 cDNA. In accordance to Gamper and
Shapiro [24], anti-CaM antibodies revealed a faint endogenous CaM
band in untransfected cells; by contrast, stronger signals were detected
by these antibodies upon CaM or CaM1234 cotransfection (1:5 cDNA
ratio for Kv7.2 and CaM or CaM1234) (Fig. 4B). Despite the identicalTable 1
Summary of the Kv7.2CT binding parameters obtained using 12.5 nM D-CaM.
GST–Kv7.2CT −Ca2+ (EGTA 10 mM)
Maximal ﬂuorescence increase EC50 (nM) h (n)
WTa 111.0 ± 1.4 11.0 ± 0.5 1.6 ± 0.3
W344R 113.0 ± 1.5 9.4 ± 0.4 2.1 ± 0.2
L351V 105.0 ± 0.8 16.6 ± 0.4 1.8 ± 0.1
L351F 48.0 ± 2.3 44.5 ± 5.9 1.6 ± 0.3
Y362C 40.1 ± 2.3 75.6 ± 11.1 1.4 ± 0.2
R553Q 20.1 ± 1.2 91.3 ± 13.7 1.4 ± 0.3
A343Da 5.3 ± 0.3 N.D. N.D. (4)
h = Hill coefﬁcient.
(n) = number of independent experiments.
EC50 = concentration producing 50% of the maximal effect.
N.D. = not determined.
a Data from Alaimo and coll. [31].cDNA transfection ratio, the intensity of the band corresponding to
CaM1234 was higher than that of CaM; this might be due to true differ-
ences in the steady-state levels of the two proteins, as well as to an en-
hanced afﬁnity of the anti-CaM antibodies for CaM1234, as previously
suggested for anti-CaM antibodies from a different commercial source
[24]. Notably, biotinylation experiments revealed that CaM or CaM1234
overexpression failed to modify the ratio between the intensity of the
ODQ2BIOT/ODQ2TOT, which was 1.0 ± 0.7, 1.6 ± 1.1, or 1.5 ± 0.8 in cells
expressing Kv7.2, Kv7.2 + CaM, or Kv7.2 + CaM1234 (n = 6; p N 0.05;
Fig. 4C), suggesting that the enhancement of Kv7.2 currents observed
in electrophysiological experiments was not due to increased plasma
membrane levels of Kv7.2 subunits.
When the effects of CaM or CaM1234 co-transfectionwere investigat-
ed on the functional properties of currents expressed by Kv7.2 channels
carrying W344R, L351F, L351V, Y362C or R553Q BFNS-causing muta-
tions, widely diverging effects were found (Fig. 4D). In particular,
when compared to Kv7.2 channels, maximal current densities from
Kv7.2–L351V channels were unchanged when expressed alone as well
as upon CaM- or CaM1234 co-transfection. On the other hand, the
W344R mutation abolished Kv7.2 currents, both in the absence and in+Ca2+ (3.9 μM)
Maximal ﬂuorescence increase EC50 (nM) h (n)
(6) 115.0 ± 2.1 27.1 ± 1.2 3.4 ± 0.5 (5)
(4) 119.0 ± 0.8 23.9 ± 0.4 3.1 ± 0.1 (4)
(4) 115.0 ± 1.2 31.9 ± 0.9 2.4 ± 0.1 (4)
(4) 42.3 ± 0.9 50.1 ± 2.5 2.4 ± 0.3 (4)
(4) 40.6 ± 1.2 127.0 ± 7.5 1.9 ± 0.1 (4)
(4) 10.3 ± 0.8 105.0 ± 21.0 1.4 ± 0.3 (4)
4.8 ± 0.3 N.D. N.D. (4)
Fig. 4. Effect of BFNS-causingmutations on CaM-dependentmodulation of Kv7.2 homomeric channels. A) Concentration-dependent increase of Kv7.2 current density (measured at 0mV)
by CaM (black bars) or CaM1234 (gray bars) coexpression at different cDNAs ratio (from1:1 to 1:10), as reported. Representative current tracesmeasured in response to the indicated volt-
age protocol in cells expressing Kv7.2, Kv7.2+CaMor Kv7.2+CaM1234 (cDNA transfection ratio Kv7.2:CaM=1:5) are shown in the inset. B–C) Representative image ofWestern-blotting
experiments performed on total lysates (B) or biotinylated fractions (C) of CHO cells expressing Kv7.2, Kv7.2 + CaM, or Kv7.2 + CaM1234, as indicated (cDNA transfection ratio
Kv7.2:CaM = 1:5). The arrows and the numbers on the left of each image indicate the position of the protein marker. D) Quantiﬁcation of the current densities measured at 0 mV in
CHO cells expressing wt or mutant Kv7.2 channels alone (group of bars on the left; data from [22]), or co-expressing CaM (group of bars in the middle) or CaM1234 (group of bars on
the right). * = p b 0.05 versus Kv7.2; ** = p b 0.05 versus Kv7.2 + CaM; # = p b 0.05 versus Kv7.2 + CaM1234.
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how more complex behavior. In fact, Kv7.2–L351F and Kv7.2–R553Q
channels, both showing reduced maximal current densities in the ab-
sence of exogenous CaM, were signiﬁcantly potentiated by CaM or
CaM1234 co-expression. With CaM, the extent of current potentiation
in both these mutants appeared larger when compared to Kv7.2 chan-
nels; in fact, the percent of current increase by CaM was 60.7 ± 9.5%,
118.7 ± 21.3%, or 103.7 ± 21.0%, for Kv7.2, Kv7.2–L351F, or Kv7.2–
R553Q channels, respectively (p b 0.05 versus Kv7.2), leading to a com-
plete (L351F) or partial (R553Q) restoration of wild-type current levels.Table 2
Biophysical properties of wild-type or mutant Kv7.2 channels, in homomeric or heteromeric co
Channel n Control
V1/2 (mV) k (mV/efold)
Kv7.2 26–28 −21.3 ± 0.6 12.6 ± 0.5
Kv7.2–L351F 17–32 −22.1 ± 0.6 13.3 ± 0.7
Kv7.2–L351V 22–29 −24.1 ± 0.5# 11.1 ± 0.5
Kv7.2–Y362C 21–30 −24.3 ± 1.0# 12.3 ± 0.9
Kv7.2–R553Q 17–21 −20.6 ± 0.6 11.5 ± 0.6
Kv7.3 12–14 −36.9 ± 0.4# 5.9 ± 0.3#
Kv7.2/Kv7.3 21–24 −28.7 ± 0.3#,° 11.2 ± 0.3#,°
Kv7.2/Kv7.2–W344R/Kv7.3 14–22 −29.7 ± 0.4 9.6 ± 0.3
Kv7.2/Kv7.2–L351F/Kv7.3 20–22 −28.5 ± 0.4 10.3 ± 0.3
Kv7.2/Kv7.2–L351V/Kv7.3 18–21 −28.9 ± 0.4 10.7 ± 0.4
Kv7.2/Kv7.2–Y362C/Kv7.3 16–22 −31.0 ± 0.4$ 11.0 ± 0.3
Kv7.2/Kv7.2–R553Q/Kv7.3 18–21 −28.9 ± 0.3 10.5 ± 0.3
⁎ p b 0.05 versus respective controls without CaM.
⁎⁎ p b 0.05 versus respective controls with CaM.
# p b 0.05 versus Kv7.2.
## p b 0.05 versus Kv7.2 + CaM.
### p b 0.05 versus Kv7.2 + CaM1234.
° p b 0.05 versus Kv7.3.
$ p b 0.05 versus Kv7.2 + Kv7.3.
† p b 0.05 versus Kv7.2 + Kv7.3 + CaM1234.By contrast, with CaM1234, the percent of current increasewere identical
in Kv7.2, Kv7.2–L351F, or Kv7.2–R553Q channels (being 399.9 ± 17.5%,
463.8 ± 34.8% or 443.5 ± 23.7%, for Kv7.2, Kv7.2–L351F, or Kv7.2–
R553Q channels, respectively), and the maximal current density for
both these mutants upon CaM1234 co-transfection was still smaller
than that of wt channels. In the case of the Y362C mutant, whose cur-
rent density was similar to that of Kv7.2 channels when expressed
alone, currents recorded in CaM- or CaM1234-co-expressing cells were
larger or smaller, respectively, than those of wt channels. As for wt
channels, CaM1234 co-expression caused a signiﬁcant leftward shift innﬁguration with Kv7.3 subunits, upon CaM or CaM1234 over-expression.
+CaM +CaM1234
V1/2 (mV) k (mV/efold) V1/2 (mV) k (mV/efold)
−19.2 ± 0.5⁎ 12.4 ± 0.5 −34.7 ± 0.9⁎,⁎⁎ 13.3 ± 0.7
−20.9 ± 0.8 13.3 ± 0.7 −33.3 ± 0.6⁎,⁎⁎ 12.5 ± 0.5
−23.2 ± 0.8## 12.2 ± 0.6 −30.9 ± 0.6⁎,⁎⁎,### 13.4 ± 0.5
−23.3 ± 0.6## 11.8 ± 0.5 −28.2 ± 0.6⁎,⁎⁎,### 12.0 ± 0.5
−22.9 ± 0.7## 13.8 ± 0.6 −28.4 ± 1.1⁎,⁎⁎,### 14.1 ± 0.9
−37.4 ± 0.5 6.2 ± 0.4 −37.9 ± 0.6 6.7 ± 0.5
−30.4 ± 0.3⁎ 11.4 ± 0.3 −38.0 ± 0.5⁎⁎ 11.3 ± 0.4
−29.0 ± 0.4 9.9 ± 0.3 −36.5 ± 0.4⁎,⁎⁎ 10.4 ± 0.3
−28.0 ± 0.3 10.8 ± 0.3 −35.3 ± 0.5⁎,⁎⁎,† 12.1 ± 0.4⁎⁎
−29.9 ± 0.4 11.0 ± 0.4 −37.3 ± 0.5⁎,⁎⁎ 10.9 ± 0.4
−30.1 ± 0.4 11.1 ± 0.3 −34.9 ± 0.4⁎,⁎⁎,† 11.2 ± 0.4
−29.6 ± 0.3 10.6 ± 0.3 −35.1 ± 0.5⁎,⁎⁎,† 11.2 ± 0.4
1863P. Ambrosino et al. / Biochimica et Biophysica Acta 1852 (2015) 1856–1866the voltage-dependence of activation for eachmutant Kv7.2 channel; by
contrast, no change was measured when CaM was overexpressed
(Table 2).
Tomimic the genetic condition of the individuals affectedwith BFNS
who carry a single mutant Kv7.2 allele, we also performed electrophys-
iological recordings in CHO cells expressing mutant subunits in Kv7.2/
Kv7.3 heteromers, together with CaM or CaM1234. As previously report-
ed [5], Kv7.2 co-expression with Kv7.3 (transfection ratio 1:1, using
0.3 + 0.3 μg of cDNA) caused a signiﬁcant increase in the maximal cur-
rent density (Fig. 5) and a leftward shift in the voltage dependence
of activation (Table 2) when compared to Kv7.2 homomeric channels.
Furthermore, CaM or CaM1234 over-expression together with Kv7.2/
Kv7.3 heteromeric channels (transfection ratio 1:1:10, using
0.3 + 0.3 + 3 μg of cDNA) increased current density (Fig. 5) and pro-
moted a leftward shift in the voltage-dependence of activation
(Table 2). By contrast, CaM or CaM1234 failed to modify Kv7.3 current
size (current densities were 12.4 ± 3.2, 10.1 ± 3.4, 19.9 ± 4.2 pA/pF,
for Kv7.3, Kv7.3 + CaM or Kv7.3 + CaM1234, respectively; n = 18–26;
p N 0.05 among each other) or activation voltage-dependence
(Table 2), suggesting that Kv7.2/Kv7.3 CaM-mediated modulation is
strongly dependent on the presence of Kv7.2 subunits.
As previously reported [22], when Kv7.2–L351V or Kv7.2–Y362C
subunits were co-expressed with Kv7.2/Kv7.3 channels (transfection
ratio 0.5:0.5:1, using 0.15 + 0.15 + 0.3 μg of cDNA), no signiﬁcant
change was measured in terms of maximal current density (Fig. 5); in
cells expressing these channels, co-transfection with CaM or CaM1234
increased current levels and modiﬁed gating in a similar fashion as in
Kv7.2/Kv7.3 channels (Fig. 5; Table 2). By contrast, while we previously
reported a reduction inmaximal currents when Kv7.2–W344R subunits
were expressed together with Kv7.2/Kv7.3 subunits [22], we failed to
detect any signiﬁcant change in the present experiments (Fig. 5;
Table 2). However, in the present study, smaller amounts of Kv7.2/
Kv7.3 cDNAs were transfected (total of 0.6 μg instead of 3 μg used in
the previous study) to allow for the co-transfection of a 5-fold higher
amount (3 μg) of CaM cDNA. These results suggest that Kv7.2–W344R
mutant subunits-induced suppression of Kv7.2/Kv7.3 heteromeric
channel function strictly depends on the amount of cDNA transfected.
By contrast, L351F or R553Qmutations decreased heteromericmaximalFig. 5. Effect of BFNS-causingmutations on CaM-dependentmodulation of Kv7.2/Kv7.3 heterom
age protocol in cells expressing Kv7.2/Kv7.3, Kv7.2/Kv7.3 + CaM or Kv7.2/Kv7.3 + CaM1234 (tr
using 0.3+0.3+3 μg of cDNA for Kv7.2/Kv7.3+CaMorKv7.2/Kv7.3+CaM1234). B)Quantiﬁca
Kv7.3 channels in the absence or in the presence of co-expressed CaM or CaM1234, as indicatedcurrent density (Fig. 5),without affecting the voltage-dependence of ac-
tivation (Table 2). In cells expressing these channels, CaM over-
expression (transfection ratio 0.5:0.5:1:10, using 0.15 + 0.15 +
0.3 + 3 μg of cDNA) fully restored current density to control levels in
heteromeric channels carrying Kv7.2–L351F or Kv7.2–R553Q mutant
subunits. Instead, CaM1234 over-expression only partially restored chan-
nel function, and promoted a leftward shift in the voltage-dependence
of activation (Table 2).
4. Discussion
The KCNQ2 gene is a major locus for BFNS, and studies in hetero-
logous expression systems and in mice models converge on the
hypothesis that a decrease in IKM function (underlied by KCNQ2-
encoded Kv7.2 subunits) is sufﬁcient to cause BFNS, therefore indicating
haploinsufﬁciency as a primary pathogeneticmechanism for both famil-
ial and sporadic BFNS cases [39]. Twomain general mechanisms can ac-
count for mutation-induced decrease in Kv7.2 currents: defects in
voltage-sensing mostly caused by mutations affecting the S1–S4
voltage-sensing domain [8,40,41], and defective subunit stability [42]
and trafﬁcking [32], subcellular targeting [43], or regulation by
intracellularly-acting modulators [22,44] for those mutations affecting
the long intracellular C-terminal domain. In Kv7 channels, this region
provides attachment sites for several regulatory molecules [34,35];
among these, CaM binds to two non-continuous α helical regions
(called A and B helices) [14]. In the present work, recently described
BFNS-causing mutations [22] falling in Kv7.2 C-terminus helix A
(W344R, L351F, L351V), helix B (R553Q), or A–B inter-helical region
(Y362C) have been investigated with respect to their ability to affect
CaM binding and CaM-dependent Kv7.2 or Kv7.2/Kv7.3 functional
modulation.
To this aims, Kv7.2/CaM interaction has been studied by semi-
quantitative (Far-Western blotting experiments) and quantitative
(D-CaM ﬂuorescence and SPR assays) biochemical approaches. For
these experiments, a large amount of CaM was easily puriﬁed in native
conﬁguration. Instead, Kv7.2 C-terminal fragments were much more
difﬁcult to purify because of their marked tendency to aggregate; there-
fore, they were either extracted from inclusion bodies from totaleric channels. A) Representative current tracesmeasured in response to the indicated volt-
ansfection ratio 1:1, using 0.3 + 0.3 μg of cDNA for Kv7.2/Kv7.3; transfection ratio 1:1:10,
tion of the current densitiesmeasured at 0mV inCHO cells expressingwt ormutant Kv7.2/
. * = p b 0.05 versus Kv7.2/Kv7.3; # = p b 0.05 versus Kv7.2/Kv7.3 + CaM1234.
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ﬂuorescence measurements) or used without any puriﬁcation proce-
dure to preserve maximal protein activity (as in Far-Western blotting
and SPR experiments, both requiring larger protein amounts). Since
CaM-mediated target protein regulation is often dependent on [Ca2+]i
[45,46], D-CaM experiments were performed both in the presence and
in the absence of Ca2+; by contrast, technical limitations impeded the
evaluation of Kv7.2 afﬁnity for CaM in the absence of Ca2+ in SPR exper-
iments. Nevertheless, the similarity in CaM afﬁnities when these were
measured for each Kv7.2 C-terminal construct in the presence of Ca2+
by two very different techniques, namely D-CaM ﬂuorescence and SPR
experiments, is strongly suggestive of the biological relevance of the ob-
served differences. This view was also conﬁrmed by the fact that, using
all three experimental approaches (Far-Western blotting, SPR, and D-
CaM ﬂuorescence), CaM binding was abolished or strongly diminished
by the A343D mutation in helix A, as previously demonstrated [32,36].
The biochemical results obtained suggest that CaM binds to Kv7.2 C-
terminus with higher afﬁnity in the absence of Ca2+. TheW344Rmuta-
tion failed to affect CaMbinding, either in the presence or in the absence
of Ca2+; a similar pattern was also observed with the L351V mutation,
although this substitution slightly (but signiﬁcantly) reduced CaMafﬁn-
ity both in the presence and in the absence of Ca2+. By contrast, the
L351F, Y362C, and R553Q mutations signiﬁcantly reduced CaM afﬁnity
in the presence or absence of Ca2+; in the case of the L351F and
R553Q, identical CaM afﬁnities were observed both in the presence
and in the absence of the divalent cation.
To evaluate the functional consequences of the mutation-induced al-
tered CaM binding revealed by biochemical experiments, an assay for
CaM-dependent Kv7.2 current regulation was developed. In fact, we
found that Kv7.2 currents were potentiated in a dose-dependentmanner
by CaM overexpression; an even stronger current enhancement was ob-
served upon Kv7.2 co-expression with CaM1234, a CaM isoform unable to
bind Ca2+ [23]. CaM binding has been shown to play a crucial role in the
export from the endoplasmic reticulum and plasma membrane expres-
sion of Kv7.2 channels expressed in HEK cells [36], and for polarized axo-
nal surface expression of Kv7.2 subunits in rat hippocampal neurons [44].
Furthermore, CaM binding to the C-terminus regulates Kv7.2 assembly
with Kv7.3, thus inﬂuencing expression of heteromeric channels at the
axon initial segment [47]. In our experiments, we tested whether the ob-
served CaM-induced current potentiation was related to an increase in
plasmamembrane expression of Kv7.2 subunits usingmembrane protein
biotinylation. The results obtained suggested that CaM- or CaM1234-
induced Kv7.2 current potentiation could not be accounted for by an in-
crease in plasma membrane trafﬁcking of channel subunits. Rather,
given that CaM is unlikely to inﬂuence the single channel conductance,
an effect on the opening probability, mainly regulated by PIP2 afﬁnity
[13] appears as a likely explanation. The observed difference between
CaM and CaM1234 in Kv7.2 current potentiation could be attributed to
the fact that, while Ca2+-unbound CaM (apo-CaM) appears mainly to
play a permissive role on channel open state [45], Ca2+-CaM (holo-
CaM) mediates inhibitory signals [24], preferentially inducing channel
closure [48]. The ability of CaM (and of apo-CaM, in particular) to regulate
channel gating is consistent with recent results obtained with CaM pro-
teins chemically derivatized with tethered pore blockers of different
lengths, showing that the CaM binding site is positioned rather close to
the cytoplasmic gate of Kv7.2 channels [49]. Consistent with this view is
also the present observation that CaM1234, but not CaM, overexpression,
beside increasing the maximal current density, also prompted a robust
leftward shift in the voltage-dependence of activation of Kv7.2 and
Kv7.2/Kv7.3 currents, indicative of an increased sensitivity to voltage of
the opening process. Previous reports suggested that CaM (but not
CaM1234) overexpression reduced Kv7.2 maximal current density [50];
differences in the electrophysiological recording technique (whole-cell
or perforated patch-mode), in the intracellular solution composition
(EGTA concentrations, in particular), and in Kv7.2:CaM co-transfected
cDNA ratios could explain this discrepancy. In addition, differences inthe Kv7.2 splice variants diverging in the A–B linker might also provide
a plausible explanation; in fact, while isoform c has been used in present
experiments, those from Gamper and Shapiro [50] were instead per-
formed with isoform d (GenBank accession no. AF_110020). As a matter
of fact, splice variant-dependent currentmodulation by CaM1234 (but not
by CaM) has been described in closely-related Kv7.4 channels [51].
Using the described functional assay, it was found that the W344R
mutation, despite binding CaM with wt afﬁnity, did not express func-
tional currents when expressed homomerically [22], also when co-
expressed with CaM or CaM1234. These results suggested that the
W344 residue is involved in the structural rearrangements translating
CaMbinding into pore gating, therefore playing a critical role in favoring
channel opening upon CaM binding, and revealing that CaM binding is
essential, but not sufﬁcient for pore opening. The presence of an aromat-
ic side chain at the W344 position, despite being dispensable for CaM
binding, is strictly required for Kv7.2 channel function [22], and an aro-
matic residue is often found at the corresponding position in the IQ
CaM-binding motif in many CaM target proteins [46]. By contrast, all
the other previously-studied mutations in helix A reduced CaM binding
to Kv7.2 [36], and abolished (I340E, A343D) or strongly reduced
(R353G, another mutation found in a BFNS family; [52]) Kv7.2 currents.
On the other hand, currents expressed by L351F– or R553Q–Kv7.2
mutant channels, whichwere smaller than those carried bywt channels
when expressed alone, were consistently increased by CaM- or CaM1234
overexpression. In CaM-co-expressing cells, the extent of current poten-
tiation in both Kv7.2–L351F or Kv7.2–R553Qmutantswas larger than in
wt channels, leading to a full (in the case of L351F) or an almost com-
plete (for R553Q) normalization of the maximal current density; these
results suggest that the reduced size of the currents expressed by
Kv7.2 channels carrying each of these mutants in the absence of added
CaM can be attributed to amutation-dependent reduction in CaM afﬁn-
ity. The results obtained are qualitatively similar to those described for
other mutations in the A (I340A; [31]) or B (S539D; corresponding to
the S511D reported in the splice variant studied by Alaimo and coll.
[31]) helix which failed to carry signiﬁcant currents when expressed
alone, but were rescued by CaM or CaM1234 co-expression. Structural
studies have revealed that the residue corresponding to R553 in
highly-homologous Kv7.4 subunits is involved in electrostatic interac-
tions with CaM [48]; the pathophysiological relevance of such ﬁnding
seems also supported by the observation that the Kv7.2–R553 residue
immediately precedes another positively charged, CaM-interacting res-
idue [48], which has been found mutated in an atypical BFNS-affected
family (K554N; [53]). Noteworthy, non-aromatic side chain at the
L351 position seems to be an important structural requirement for
proper CaM-induced regulation of Kv7.2 channel function; in fact, the
L351V substitution, opposite to the more disruptive L351F substitution,
only slightly reduced Kv7.2 afﬁnity for both CaM and CaM1234, and
displayed a neutral behavior in our functional tests.
Finally, the Y362C mutation, which did not alter steady-state Kv7.2
current levels in control condition, reduced CaM afﬁnity in biochemical
experiments and affected CaM- and CaM1234-induced current regula-
tion in electrophysiological experiments, suggesting that a reduced af-
ﬁnity versus CaM is not predictive per se of a decrease in Kv7.2
currents. This result is similar to that obtained for Kv7.2 channels carry-
ing another mutation (C527R), showing altered CaM binding, but nor-
mal current levels [45]. It should be underlined that the Y362 residue
falls within the A–B interhelical region, and recent structural insights
in the highly homologous Kv7.1 channel reveal that this region is un-
likely to contribute to CaM binding [54]. However, it has been recently
suggested that the A–B linker inﬂuences PIP2 afﬁnity [19], and that an
interplay between CaM binding and PIP2 afﬁnity regulates muscarinic-
induced suppression of Kv7.2 channels [55]. Thus, we suggest that, in
thismutant, changes in PIP2 afﬁnity could counterbalance the functional
effects caused by the reduced CaM afﬁnity.
To further explore the pathophysiological relevance of these ﬁndings
for BFNS patients,who carry a single Kv7.2mutated allele,we also studied
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theKv7.2/Kv7.3 genetic balance found inBFNS individuals. The results ob-
tained suggest that the reduction in current size observed in heteromeric
Kv7.2/Kv7.3 channels incorporating Kv7.2–L351F or Kv7.2–R553Q mu-
tant subunits was fully reversed by CaM over-expression; instead, in
both these mutants, CaM1234 overexpression, although strongly enhanc-
ing channel function, failed to restore current levels to control values.
No functional difference was observed in the case of the W344R, L351V,
andY362Cmutations between control andCaM- (or CaM1234) transfected
cells. Thus, mainly quantitative differences occurred in CaM- or CaM1234-
induced regulation when Kv7.2 mutant subunits are incorporated into
homomers or into heteromeric channels with Kv7.2 and Kv7.3 subunits.
Particularly striking is the behavior of theW344Rmutation, which gener-
ated non-functional channels when expressed in homomeric conﬁgura-
tion, but failed to interfere with the currents carried by Kv7.2/Kv7.3
subunits. Thus, although additional studies are needed to better elucidate
the pathogenic mechanism by which this mutation is epileptogenic in
humans, changes in CaM afﬁnity appear unlikely.
Noteworthy, the changes in CaM-dependent Kv7.2 modulation
prompted by some of the BFNS-associated mutations herein described
cannot be considered exhaustive of the complex possible mechanisms
by which these mutations affect Kv7.2 channel function. Noteworthy,
the same mutations also interfere with the functional regulation by
syntaxin-1A [22], a member of the soluble N-ethylmaleimide-
sensitive-factor attachment protein receptor (SNARE) complex, which
downregulates Kv7.2 channel gating by binding to a site on Kv7.2 chan-
nels largely overlapping that of CaM [16]. A further study from the same
group [21] also reported that co-expression of CaM with syntaxin in-
creased CaM binding to Kv7.2, although it fully blocked the inhibitory
effect of syntaxin on Kv7.2 current amplitude; in their experiments,
these Authors also showed by ﬂuorescence resonance energy transfer
experiments that the functional changes produced by CaM on channel
gating are accompanied by an increased proximity between the N-
and C-termini. The ability of Kv7.2 mutations to interfere with both
CaM- (this study) and syntaxin- [22] induced functional regulation is
suggestive of a potentially competitive interaction between these two
regulators involving the C-terminal region, although further studies
are needed to conﬁrm such an hypothesis. Furthermore, it should be
considered that other regulatory pathways (including PKC phosphory-
lation or PIP2 binding), also acting at the same C-terminal region,
could be affected by these mutations.
It should be pointed out that, in the present experiments, the conse-
quences of the mutations on CaM binding have been investigated using
Kv7.2 C-terminal fragments rather than the full-length channel subunit;
thus, the correlation between biochemical and functional results must
be viewed with caution. We carried out several attempts in co-
immunoprecipitation experiments with different Kv7.2 and CaM con-
structs and antibodies, but severe technical limitations precluded a pre-
cise quantiﬁcation of the afﬁnity between the two interacting proteins
(data not shown). Nevertheless, despite such potential limitation, each
of the BFNS-causing mutations in Kv7.2 C-terminal region herein investi-
gated appear to prompt speciﬁc biochemical and/or functional conse-
quences, ranging from slight alterations in CaM afﬁnity which did not
translate into functional changes (L351V), to a signiﬁcant reduction in
the afﬁnity and functional modulation by CaM (L351F, Y362C or
R553Q), to a complete abolishment of functional behavior without signif-
icant alteration in CaM afﬁnity (W344R). In Kv7.2–L351F and Kv7.2–
R553Q mutants, CaM overexpression restored normal Kv7.2 or Kv7.2/
Kv7.3 channel function.
Altogether, the present results further our knowledge of the com-
plex molecular network regulating Kv7.2 channels, provide a rationale
pathogenetic mechanism for mutation-induced Kv7.2 channel dysfunc-
tion in BFNS, and highlight CaM-dependent Kv7.2 current enhancement
as a potential therapeutic approach in Kv7.2-related epilepsies.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbadis.2015.06.012.Acknowledgments
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